| A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease (NCT02679014) | Hoffmann-La Roche | 2016-03-06 |
| Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary (NCT02720783) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2016-03-04 |
| Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Tumors (NCT02456883) | Astellas Pharma Global Development, Inc. | 2016-03-04 |
| A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects (NCT05028127) | UCB Celltech | 2016-03-04 |
| A Study of SHR6390 in Advanced Solid Tumor Patients (NCT02684266) | Jiangsu HengRui Medicine Co., Ltd. | 2016-03-03 |
| A Study to Evaluate the Effect of [14C]Acp-196 (Acalabrutinib) in Healthy Adult Participants (NCT04898101) | Acerta Pharma BV | 2016-03-03 |
| Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity (NCT03829839) | University Hospital, Bonn | 2016-03-03 |
| BAX 826 Dose-Escalation Safety Study (NCT02716194) | Baxalta now part of Shire | 2016-03-03 |
| Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer (NCT02606305) | ImmunoGen, Inc. | 2016-03-02 |
| A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma (NCT02743780) | Alcon Research | 2016-03-02 |
| Study of BEBT-908 in Subjects With Advanced Hematological Tumors (NCT06082596) | BeBetter Med Inc | 2016-03-02 |
| An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis (NCT02205515) | Sunnybrook Health Sciences Centre | 2016-03-01 |
| Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission (NCT02632396) | Emory University | 2016-03-01 |
| A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer. (NCT02726334) | Bionomics Limited | 2016-03-01 |
| Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories (NCT02671058) | Cristcot LLC | 2016-03-01 |
| A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy (NCT02703350) | Eli Lilly and Company | 2016-03-01 |
| A Pilot Study of Rapid Haplotyping Procedure for Personalized Dosing of Dichloroacetate (DCA) in Healthy Volunteers (NCT02690285) | University of Florida | 2016-03-01 |
| Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects (NCT02709928) | Theravance Biopharma | 2016-03-01 |
| Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock (NCT02716597) | Alexander Flannery, 859-323-4011 | 2016-03-01 |
| A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers (NCT02700373) | Hapten Sciences, Inc. | 2016-03-01 |
| A Study to Establish Safety and Maximum Tolerated Dose of IV Trehalose in Healthy Subjects (NCT02725957) | Bioblast Pharma Ltd. | 2016-03-01 |
| Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer (NCT02718820) | Medical University of Vienna | 2016-03-01 |
| Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) (NCT02808416) | Guangdong 999 Brain Hospital | 2016-03-01 |
| Timolol for the Treatment of Acne and Rosacea (NCT02774590) | Johns Hopkins University | 2016-03-01 |
| Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia (NCT02674763) | ImmunoGen, Inc. | 2016-03-01 |
| Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects (NCT02741739) | Regeneron Pharmaceuticals | 2016-03-01 |
| Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected Adults (NCT02654080) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-03-01 |
| New Approaches in Evaluating Patients' Response to Botulinum Toxins in the Treatment of Chronic Neck Pain and Back Pain (NCT02008136) | VA Connecticut Healthcare System | 2016-03-01 |
| A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia (NCT02714569) | Eli Lilly and Company | 2016-03-01 |
| Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation (OXYOP) (NCT02652520) | University Hospital, Brest | 2016-03-01 |
| Evaluation of Safety and Efficacy of Estetrol in Healthy Men (NCT02718378) | Pantarhei Oncology B.V. | 2016-03-01 |
| The DDI Study of SP2086 and Simvastatin (NCT02817243) | Jiangsu HengRui Medicine Co., Ltd. | 2016-03-01 |
| Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients (NCT02439723) | AHS Cancer Control Alberta | 2016-03-01 |
| A Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male Participants (NCT02674295) | Janssen Research & Development, LLC | 2016-03-01 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis (NCT02748993) | Amorepacific Corporation | 2016-03-01 |
| The DDI Study of SP2086 and Valsartan (NCT02817217) | Jiangsu HengRui Medicine Co., Ltd. | 2016-03-01 |
| ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes (NCT02840617) | Third Affiliated Hospital, Sun Yat-Sen University | 2016-03-01 |
| Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies (NCT02648724) | Symphogen A/S | 2016-03-01 |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery (NCT02583269) | Wake Forest University Health Sciences | 2016-03-01 |
| DP-R208 Pharmacokinetic Study (NCT02709187) | Alvogen Korea | 2016-03-01 |
| Alkaline Ionized Water: Sports Recovery and Inflammation Management (NCT02748655) | Natural Immune Systems Inc | 2016-03-01 |
| CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma (NCT02742727) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-03-01 |
| First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer (NCT02716012) | Mina Alpha Limited | 2016-03-01 |
| Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II (NCT02710097) | Yale University | 2016-03-01 |
| Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 (NCT02024009) | University of Oxford | 2016-03-01 |
| Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL) (NCT02669264) | ADC Therapeutics S.A. | 2016-03-01 |
| the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy Volunteers (NCT02821871) | Jiangsu HengRui Medicine Co., Ltd. | 2016-03-01 |
| A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment (NCT02711969) | Bukwang Pharmaceutical | 2016-03-01 |
| Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations (NCT02707913) | Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited | 2016-03-01 |
| Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg (NCT02742324) | French Innovative Leukemia Organisation | 2016-03-01 |
| An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates (NCT02819102) | BioCryst Pharmaceuticals | 2016-03-01 |
| Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma (NCT02876978) | CARsgen Therapeutics Co., Ltd. | 2016-03-01 |
| A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment (NCT02709382) | Wockhardt | 2016-03-01 |
| A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy (NCT02703337) | Eli Lilly and Company | 2016-03-01 |
| Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer (NCT02627430) | National Cancer Institute (NCI) | 2016-03-01 |
| Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake (NCT02517593) | Mayo Clinic | 2016-03-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers (NCT02757144) | Daewoong Pharmaceutical Co. LTD. | 2016-03-01 |
| Open-label, Bioequivalence Study of Certolizumab Pegol 200 mg Solution Injected Either by a Prefilled Syringe (Reference) or by an E-Device (Test) in Healthy Subjects (NCT02806219) | UCB BIOSCIENCES, Inc. | 2016-03-01 |
| A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression (NCT02512237) | Zhejiang Medicine Co., Ltd. | 2016-03-01 |
| Cryoanesthesia for Intravitreal Injections (NCT02872012) | University of Michigan | 2016-03-01 |
| Bioequivalence Study of CRushed TriUMeq With or Without Drip Feed Compared to the Whole Tablet (NCT02569346) | Radboud University Medical Center | 2016-03-01 |
| Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil) (NCT03173742) | Insud Pharma | 2016-03-01 |
| NAC to Prevent Cisplatin-induced Hearing Loss (NCT02094625) | Children's Hospital Los Angeles | 2016-03-01 |
| A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block (NCT02850484) | Intech Biopharm Ltd. | 2016-03-01 |
| 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR (NCT02717572) | Washington University School of Medicine | 2016-03-01 |
| A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma (NCT02706782) | Shanghai GeneChem Co., Ltd. | 2016-03-01 |
| Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older (NCT02665871) | Beijing Chaoyang District Centre for Disease Control and Prevention | 2016-03-01 |
| Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer (NCT02672475) | Vanderbilt-Ingram Cancer Center | 2016-03-01 |
| Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer (NCT02748889) | Giuseppe Giaccone | 2016-03-01 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer (NCT02725606) | Jiangsu T-Mab Biopharma Co.,Ltd | 2016-03-01 |
| Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers (NCT02954276) | Targia Pharmaceuticals Ltd. | 2016-03-01 |
| Hematopoietic Stem Cell Transplant Survivors Study (NCT02652052) | Mayo Clinic | 2016-03-01 |
| Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment (NCT02967874) | Russian Academy of Medical Sciences | 2016-03-01 |
| Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers (NCT02690961) | Tianjin Chasesun Pharmaceutical Co., LTD | 2016-03-01 |
| A Phase I Study of PLX038 in Patients With Advanced Solid Tumors (NCT02646852) | ProLynx LLC | 2016-03-01 |
| The Impact of Modified Wheat Bran on Carbohydrate Fermentation in the Colon in Healthy and Obese Subjects (NCT02796989) | KU Leuven | 2016-03-01 |
| First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor (NCT02661373) | St. Jude Children's Research Hospital | 2016-03-01 |
| A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects (NCT02704702) | Boryung Pharmaceutical Co., Ltd | 2016-03-01 |
| Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)? (NCT02348125) | Drexel University | 2016-03-01 |
| Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) (NCT02709616) | Guangdong 999 Brain Hospital | 2016-03-01 |
| A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies (NCT02710149) | Southwest Hospital, China | 2016-03-01 |
| Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma (NCT02548962) | Pharmacyclics LLC. | 2016-03-01 |
| SINF: Peripheral Neuropathy in Cancer Survivors (NCT02168894) | M.D. Anderson Cancer Center | 2016-03-01 |
| A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps (NCT02703324) | Eli Lilly and Company | 2016-03-01 |
| DSM265 Prophylaxis of Plasmodium Falciparum Malaria (NCT02562872) | Medicines for Malaria Venture | 2016-03-01 |
| rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies (NCT02710500) | Sarepta Therapeutics, Inc. | 2016-03-01 |
| Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD (NCT02525029) | Masonic Cancer Center, University of Minnesota | 2016-03-01 |
| Delayed Release Diclofenac Sodium Formulation vs Voltaren® (NCT02714842) | BDD Pharma Ltd | 2016-03-01 |
| Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants (NCT02706834) | Takeda | 2016-03-01 |
| Autologous Bulbar Olfactory Ensheathing Cells and Nerve Grafts for Treatment of Patients With Spinal Cord Transection (NCT03933072) | Nicholls Spinal Injury Foundation | 2016-03-01 |
| Study of JS001 in Participants With Advanced Solid Tumors (NCT02857166) | Shanghai Junshi Bioscience Co., Ltd. | 2016-03-01 |
| Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2) (NCT02808364) | Guangdong 999 Brain Hospital | 2016-03-01 |
| Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients (NCT02721407) | Xinqiao Hospital of Chongqing | 2016-03-01 |
| Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis (NCT02809183) | Tricida, Inc. | 2016-03-01 |
| CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT. (NCT02752243) | Peter Bader | 2016-03-01 |
| Assessing the Bite Counter (NCT02763358) | Medical University of South Carolina | 2016-03-01 |
| Cognitive-Behavioral Rehabilitation for Bipolar Disorder (NCT02766361) | University of Sao Paulo | 2016-03-01 |
| Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III (NCT02710331) | Yale University | 2016-03-01 |
| A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) (NCT02766634) | Pfizer | 2016-03-01 |
| Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers (NCT01686139) | Sheba Medical Center | 2016-03-01 |